Junqiang Ding

Branched PEG-modification: A new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy

Min Liu, Jie Li, Dan Zhao et al. · Biomaterials · 2022 · 82 citations

Pharmacy, Oncology, Pharmaceutics +16

Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapy

Junqiang Ding, Dezhi Sui, Mingqi Liu et al. · Acta Biomaterialia · 2021 · 60 citations

Medicine, Cancer Biology, Oncology +15

Accelerated Blood Clearance of Nanoemulsions Modified with PEG-Cholesterol and PEG-Phospholipid Derivatives in Rats: The Effect of PEG-Lipid Linkages and PEG Molecular Weights

Mengyang Liu, Yanyi Chu, Huan Liu et al. · Molecular Pharmaceutics · 2019 · 44 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Terminating the renewal of tumor-associated macrophages: A sialic acid-based targeted delivery strategy for cancer immunotherapy

Junqiang Ding, Dan Zhao, Yawei Hu et al. · International Journal of Pharmaceutics · 2019 · 38 citations

Medicine, Immunology, Oncology +16

Effects of stability of PEGylated micelles on the accelerated blood clearance phenomenon

Yuqing Su, Mengyang Liu, Yan Xiong et al. · Drug Delivery and Translational Research · 2018 · 27 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +12